GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AGEN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Agenus Inc. stock price on Friday moving between $4.91 and $5.87
(Updated on Apr 19, 2024)

Buy candidate since Apr 17, 2024 Loss -1.67% PDF

The Agenus Inc. stock price gained 6.84% on the last trading day (Friday, 19th Apr 2024), rising from $4.97 to $5.31. During the last trading day the stock fluctuated 19.67% from a day low at $4.91 to a day high of $5.87. The price has fallen in 7 of the last 10 days but is still up by 954.2% over the past 2 weeks. Volume fell on the last day by -208 thousand shares and in total, 1 million shares were bought and sold for approximately $7.76 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 45.12% during the next 3 months and, with a 90% probability hold a price between $1.01 and $12.13 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AGEN Signals & Forecast

The Agenus Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.30 and $1.52. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, April 12, 2024, and so far it has fallen -34.85%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Agenus Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.97. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.97 between high and low, or 19.67%. For the last week, the stock has had daily average volatility of 25.25%.

Our recommended stop-loss: $5.04 (-5.08%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 5 days ago.)

Trading Expectations (AGEN) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Agenus Inc. to open at $5.36, and during the day (based on 14 day Average True Range), to move between $4.43 and $6.19, which gives a possible trading interval of +/-$0.88 (+/-16.49%) up or down from last closing price. If Agenus Inc. takes out the full calculated possible swing range there will be an estimated 32.98% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.40 (1.69%) than the support at $4.97 (6.40%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Agenus Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Agenus Inc. stock to perform well in the short-term.

Current score: 2.489 Buy Candidate Unchanged

Predicted Opening Price for Agenus Inc. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$5.36 ( 0.97%) $5.31

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AGEN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 6.33 19.15 %
R2 5.96 12.20 %
R1 5.73 7.92 %
Current price: 5.31
Support S1 4.99 -5.97 %
S2 4.77 -10.26 %
S3 4.40 -17.20 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.50 22.41 %
R2 6.30 18.64 %
R1 5.40 1.69 %
Current price 5.31
Support S1 4.97 -6.40%
S2 0 .
S3 0 .

FAQ

What is the symbol for Agenus Inc. Stock and on which exchange is it traded?
The symbol for Agenus Inc. is AGEN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Agenus Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Agenus Inc. stock to perform well in the short-term.

How to buy Agenus Inc. Stock?
Agenus Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Agenus Inc. Stock.

What's the current price of Agenus Inc. Stock?
As of the end of day on the 2024-04-19, the price of an Agenus Inc. (AGEN) share was $5.31.

What is the 52-week high and low for Agenus Inc. Stock?
The 52-week high for Agenus Inc. Stock is $9.22 and the 52-week low is $0.410.

What is the market capitalization of Agenus Inc. Stock?
As of the 2024-04-19, the market capitalization of Agenus Inc. is 111.223M.

When is the next earnings date for Agenus Inc.?
The upcoming earnings date for Agenus Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Agenus Inc.

Agenus. Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The... AGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT